KIDS - OrthoPediatrics Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

OrthoPediatrics Corp.

2850 Frontier Drive
Warsaw, IN 46582
United States

Full Time Employees80

Key Executives

NameTitlePayExercisedYear Born
Mr. Mark C. ThrodahlPres, CEO & Director505kN/A1951
Mr. Fred L. HiteCFO & Director472.42kN/A1968
Mr. Daniel J. GerritzenVP of Legal & HR, Gen. Counsel and Sec.335.72kN/A1970
Mr. David R. BaileyExec. VP395.5kN/A1979
Mr. Gregory A. OdleExec. VP of Commercialization395.5kN/A1970
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.

Corporate Governance

OrthoPediatrics Corp.’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.